메뉴 건너뛰기




Volumn 122, Issue 9, 2009, Pages 1067-1071

Effects of advanced glycosylation end products and rosiglitazone on the expression and secretion of galectin-3 in human renal mesangial cells

Author keywords

Advanced; Diabetic nephropathies; Galectin 3; Glycosylation end products; Mesangial cells; Rosiglitazone

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; GALECTIN 3; ROSIGLITAZONE;

EID: 68149161690     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.09.011     Document Type: Article
Times cited : (3)

References (23)
  • 2
    • 0034813639 scopus 로고    scopus 로고
    • The role of galectin-3 in endocytosis of advanced glycosylation end products and modified low density lipoproteins
    • Zhu W, Sano H, Nagai R, Fukuhara K, Miyazaki A, Horiuchi S. The role of galectin-3 in endocytosis of advanced glycosylation end products and modified low density lipoproteins. Biochem Biophys Res Commun 2001; 280: 1183-1188.
    • (2001) Biochem Biophys Res Commun , vol.280 , pp. 1183-1188
    • Zhu, W.1    Sano, H.2    Nagai, R.3    Fukuhara, K.4    Miyazaki, A.5    Horiuchi, S.6
  • 3
    • 17944369113 scopus 로고    scopus 로고
    • Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice
    • Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, et al. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J 2001; 15: 2471-2479.
    • (2001) FASEB J , vol.15 , pp. 2471-2479
    • Pugliese, G.1    Pricci, F.2    Iacobini, C.3    Leto, G.4    Amadio, L.5    Barsotti, P.6
  • 4
    • 13644263258 scopus 로고    scopus 로고
    • Oral antidiabetic agents
    • Krentz AJ, Bailey CJ. Oral antidiabetic agents. Drugs 2005; 65: 385-411.
    • (2005) Drugs , vol.65 , pp. 385-411
    • Krentz, A.J.1    Bailey, C.J.2
  • 5
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • Yki-Järvinen H. Thiazolidinediones. N Engl J Med 2004; 351: 1106-1118.
    • (2004) N Engl J Med , vol.351 , pp. 1106-1118
    • Yki-Järvinen, H.1
  • 6
    • 23644456172 scopus 로고    scopus 로고
    • Therapeutic roles of peroxisome proliferator-activated receptor agonists
    • Staels B, Fruchart J. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005; 54: 2460-2470.
    • (2005) Diabetes , vol.54 , pp. 2460-2470
    • Staels, B.1    Fruchart, J.2
  • 8
    • 30544448497 scopus 로고    scopus 로고
    • Reduction of serum advanced glycosylation end products-peptide and monocyte chemoattractant protein-1 by rosiglitazone in type 2 diabetic rats
    • Sun ZL, Liu NF, Sun YZ, Wei Q, Zhang Y, Sun GJ, et al. Reduction of serum advanced glycosylation end products-peptide and monocyte chemoattractant protein-1 by rosiglitazone in type 2 diabetic rats. J Chin Pharm Univ (Chin) 2005; 36: 559-562.
    • (2005) J Chin Pharm Univ (Chin) , vol.36 , pp. 559-562
    • Sun, Z.L.1    Liu, N.F.2    Sun, Y.Z.3    Wei, Q.4    Zhang, Y.5    Sun, G.J.6
  • 9
    • 34248664111 scopus 로고    scopus 로고
    • Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells
    • Yan HD, Li XZ, Xie JM, Li M. Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells. Chin Med J 2007; 120: 787-793.
    • (2007) Chin Med J , vol.120 , pp. 787-793
    • Yan, H.D.1    Li, X.Z.2    Xie, J.M.3    Li, M.4
  • 10
    • 68149155918 scopus 로고    scopus 로고
    • Expression of advanced glycation end products receptors on human joint synovial cells
    • Hou FF, Jiang JP, Zhang X. Expression of advanced glycation end products receptors on human joint synovial cells. Chin J Nephrol (Chin) 2000; 16: 163-168.
    • (2000) Chin J Nephrol (Chin) , vol.16 , pp. 163-168
    • Hou, F.F.1    Jiang, J.P.2    Zhang, X.3
  • 11
    • 17644434954 scopus 로고    scopus 로고
    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression
    • Pugliese G, Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, et al. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes 2000; 49: 1249-1257.
    • (2000) Diabetes , vol.49 , pp. 1249-1257
    • Pugliese, G.1    Pricci, F.2    Leto, G.3    Amadio, L.4    Iacobini, C.5    Romeo, G.6
  • 12
    • 0346368386 scopus 로고    scopus 로고
    • Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells
    • Seki N, Hashimoto N, Sano H, Horiuchi S, Yagui K, Makino H, et al. Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells. Metabolism 2003; 52: 1558-1563.
    • (2003) Metabolism , vol.52 , pp. 1558-1563
    • Seki, N.1    Hashimoto, N.2    Sano, H.3    Horiuchi, S.4    Yagui, K.5    Makino, H.6
  • 14
    • 11144267118 scopus 로고    scopus 로고
    • Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium
    • McFarlane S, Glenn JV, Lichanska AM, Simpson DA, Stitt AW. Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium. Br J Ophthalmol 2005; 89: 107-112.
    • (2005) Br J Ophthalmol , vol.89 , pp. 107-112
    • McFarlane, S.1    Glenn, J.V.2    Lichanska, A.M.3    Simpson, D.A.4    Stitt, A.W.5
  • 16
    • 9444289275 scopus 로고    scopus 로고
    • Galectin-3/AGE-receptor 3 knock out mice show accelerated AGE-induced glomerular injury: Evidence for a protective role of galectin-3 as an AGE receptor
    • Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, et al. Galectin-3/AGE-receptor 3 knock out mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB J 2004; 18: 1773-1775.
    • (2004) FASEB J , vol.18 , pp. 1773-1775
    • Iacobini, C.1    Menini, S.2    Oddi, G.3    Ricci, C.4    Amadio, L.5    Pricci, F.6
  • 18
    • 33744534329 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma agonists in renal disease
    • Pedro I, Juan JD. Peroxisome proliferator-activated receptor gamma agonists in renal disease. Eur J Endocrinol 2006; 154: 613-621.
    • (2006) Eur J Endocrinol , vol.154 , pp. 613-621
    • Pedro, I.1    Juan, J.D.2
  • 19
    • 0034033786 scopus 로고    scopus 로고
    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats
    • Isshiki K, Haneda M, Koya D, Maeda S, Sugimoto T, Kikkawa R. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 2000; 49: 1022-1032.
    • (2000) Diabetes , vol.49 , pp. 1022-1032
    • Isshiki, K.1    Haneda, M.2    Koya, D.3    Maeda, S.4    Sugimoto, T.5    Kikkawa, R.6
  • 20
    • 0034810884 scopus 로고    scopus 로고
    • Cellular mechanisms in the development and progression of diabetic nephropathy: Activation of the DAG-PKC-ERK pathway
    • Haneda M, Koya D, Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 2001; 38 (4 Suppl 1): s178-s181.
    • (2001) Am J Kidney Dis , vol.38 , Issue.4 SUPPL. 1
    • Haneda, M.1    Koya, D.2    Kikkawa, R.3
  • 21
    • 21344466513 scopus 로고    scopus 로고
    • Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients
    • Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross P. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 2005; 54: 2206-2211.
    • (2005) Diabetes , vol.54 , pp. 2206-2211
    • Pistrosch, F.1    Herbrig, K.2    Kindel, B.3    Passauer, J.4    Fischer, S.5    Gross, P.6
  • 22
    • 0034758754 scopus 로고    scopus 로고
    • Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria
    • Nakamura T, Ushiyama C, Osada S, Hara M, Shimada N, Koide H. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 2001; 50: 1193-1196.
    • (2001) Metabolism , vol.50 , pp. 1193-1196
    • Nakamura, T.1    Ushiyama, C.2    Osada, S.3    Hara, M.4    Shimada, N.5    Koide, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.